Novartis posts Cosentyx nail psoriasis and imatinib results; Piqray label updatedOct 30Weekly roundup, 8 itemsalpelisibeverolimusUpdated
Novartis registers new Phase IIIb IgAN trial and VEXAS Phase 2; gMG trial still activeOct 2Weekly roundup, 10 itemsarumakimigatrasentanUpdated